DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,876,702 | -32.6% | 5,032,501 | +79.9% | 1.58% | -33.9% |
| Q2 2023 | $17,624,256 | +9.2% | 2,797,501 | 0.0% | 2.40% | +3.8% |
| Q1 2023 | $16,141,581 | -43.8% | 2,797,501 | 0.0% | 2.31% | -31.3% |
| Q4 2022 | $28,702,360 | -38.6% | 2,797,501 | 0.0% | 3.36% | -41.5% |
| Q3 2022 | $46,774,000 | +19.4% | 2,797,501 | 0.0% | 5.75% | -20.0% |
| Q2 2022 | $39,165,000 | -13.3% | 2,797,501 | 0.0% | 7.18% | +22.7% |
| Q1 2022 | $45,180,000 | -23.9% | 2,797,501 | +0.9% | 5.86% | -4.3% |
| Q4 2021 | $59,359,000 | +45.7% | 2,772,501 | 0.0% | 6.12% | +108.4% |
| Q3 2021 | $40,728,000 | -25.1% | 2,772,501 | +1.5% | 2.94% | -35.7% |
| Q2 2021 | $54,349,000 | -33.5% | 2,732,501 | 0.0% | 4.57% | -42.7% |
| Q1 2021 | $81,702,000 | – | 2,732,501 | – | 7.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,626,476 | $78,771,000 | 38.55% |
| Logos Global Management LP | 2,797,501 | $39,165,000 | 7.18% |
| Cormorant Asset Management, LP | 5,500,000 | $77,000,000 | 5.82% |
| Ghost Tree Capital, LLC | 275,000 | $3,850,000 | 2.00% |
| EcoR1 Capital, LLC | 2,634,178 | $36,878,000 | 1.27% |
| RA Capital Management | 2,186,636 | $30,613,000 | 0.82% |
| Vivo Capital, LLC | 476,589 | $6,672,000 | 0.67% |
| Avoro Capital Advisors LLC | 2,222,222 | $31,111,000 | 0.62% |
| Artal Group S.A. | 400,000 | $5,600,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $6,445,000 | 0.19% |